Edmonds Duncan Registered Investment Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,747
| Closed | -$279K | – | 142 |
|
|
2024
Q1 | $279K | Hold |
17,747
| – | – | 0.07% | 114 |
|
|
2023
Q4 | $286K | Hold |
17,747
| – | – | 0.07% | 100 |
|
|
2023
Q3 | $226K | Hold |
17,747
| – | – | 0.06% | 121 |
|
|
2023
Q2 | $250K | Hold |
17,747
| – | – | 0.08% | 109 |
|
|
2023
Q1 | $274K | Hold |
17,747
| – | – | 0.08% | 107 |
|
|
2022
Q4 | $291K | Hold |
17,747
| – | – | 0.09% | 95 |
|
|
2022
Q3 | $328K | Hold |
17,747
| – | – | 0.12% | 85 |
|
|
2022
Q2 | $233K | Hold |
17,747
| – | – | 0.08% | 103 |
|
|
2022
Q1 | $165K | Hold |
17,747
| – | – | 0.05% | 134 |
|
|
2021
Q4 | $151K | Hold |
17,747
| – | – | 0.04% | 140 |
|
|
2021
Q3 | $603K | Hold |
17,747
| – | – | 0.18% | 77 |
|
|
2021
Q2 | $650K | Hold |
17,747
| – | – | 0.2% | 75 |
|
|
2021
Q1 | $796K | Hold |
17,747
| – | – | 0.26% | 64 |
|
|
2020
Q4 | $806K | Hold |
17,747
| – | – | 0.27% | 63 |
|
|
2020
Q3 | $910K | Hold |
17,747
| – | – | 0.38% | 50 |
|
|
2020
Q2 | $1.06M | Hold |
17,747
| – | – | 0.46% | 45 |
|
|
2020
Q1 | $731K | Hold |
17,747
| – | – | 0.37% | 52 |
|
|
2019
Q4 | $1.1M | Hold |
17,747
| – | – | 0.45% | 47 |
|
|
2019
Q3 | $602K | Hold |
17,747
| – | – | 0.25% | 58 |
|
|
2019
Q2 | $426K | Hold |
17,747
| – | – | 0.18% | 72 |
|
|
2019
Q1 | $412K | Hold |
17,747
| – | – | 0.17% | 78 |
|
|
2018
Q4 | $373K | Hold |
17,747
| – | – | 0.17% | 76 |
|
|
2018
Q3 | $687K | Hold |
17,747
| – | – | 0.28% | 56 |
|
|
2018
Q2 | $698K | Buy |
+17,747
| New | +$522K | 0.3% | 55 |
|
Other funds holding DCPH
Edmonds Duncan Registered Investment Advisors's DCPH Position: Q2 2024 in Review
Edmonds Duncan Registered Investment Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 17,747 shares — an estimated $279K sold.
Edmonds Duncan Registered Investment Advisors first reported a position in DCPH in Q2 2018 and held it in 24 quarters. The position peaked at $1.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Edmonds Duncan Registered Investment Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Edmonds Duncan Registered Investment Advisors sold 17,747 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $279K.
- Edmonds Duncan Registered Investment Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 24 quarters.
- Edmonds Duncan Registered Investment Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q2 2024, filed 16 Jul 2024.